Recent studies have reported that EGFR can be expressed in thymoma, which is an important cause of myasthenia gravis, and that EGFR overactivates the downstream PI3K/Akt/mTOR signalling pathway, inhibits apoptosis, and stimulates tumor growth [31, 32]. This evidence concerns the gene AKT1 and thymoma.